To provide the information your oncologist is not telling you or doesn't have the time to!
Exploring the Human Side of Cancer Through Art and Stories
Immerse yourself in the human experience of cancer through our “Art of Oncology” category. Here, we delve into the emotional and personal aspects of cancer diagnosis and treatment. Explore stories of courage, resilience, and hope shared by survivors, caregivers, and healthcare professionals. Experience the healing power of art, creativity, and storytelling as we navigate the profound impact of cancer on individuals and their families.
As oncologists, we are privileged to walk alongside patients and their families during some of the most challenging times in their lives. This responsibility becomes even more pronounced when we step into a role as a covering physician, whether temporarily filling in for a partner or taking on a temporary locum tenens assignments as I …
As the holiday season wraps up and 2024 comes to a close, I find myself reflecting on a year that has been both transformative and rejuvenating. This year has been different from any I’ve experienced before—a year of intentional living, personal growth, and deep gratitude. For the past 13 years, I was rooted in a …
Medical malpractice in oncology is a topic that often stirs emotions on all sides—patients, families, and physicians. For patients and caregivers, it may represent a loss of trust and unmet expectations. For providers, it can be a deeply personal challenge that touches the very heart of their commitment to care. In oncology, where time, precision, …
When facing a cancer diagnosis, timing can profoundly impact outcomes, both physically and emotionally. For some malignancies, delays in diagnosis or treatment can lead to disease progression, impacting prognosis and available treatment options. However, the urgency to act must also be balanced with the need for accurate diagnosis and a well-considered treatment plan. This article …
The recent story of unethical practices by a medical oncologist raises significant concerns and offers an opportunity to discuss red flags that patients, families, and even healthcare providers should be aware of when navigating cancer care. While most oncologists are guided by ethical principles and bound by professional accountability, recognizing warning signs can empower patients …
As an oncology research nurse, I have the unique privilege of being part of a team that brings the latest innovations in cancer treatment to life through clinical trials. My role extends far beyond the walls of the research lab or the clinic—it’s about making research accessible, meaningful, and impactful for patients who are navigating …
In oncology, where the stakes are often life and death, it’s easy to focus on clinical precision and measurable outcomes. Yet, the human side of medicine—the compassion, connection, and understanding we bring to patients and their families—can have just as profound an impact. Reading the deeply moving Art of Oncology piece published in the NEJM …
While this article is aimed at healthcare providers, its message of gratitude and reflection is for anyone seeking inspiration this Thanksgiving. This Thanksgiving weekend feels profoundly different for me—a special opportunity to step back, reflect, and express gratitude. After 13 years of service at Orlando Health, I made a life-changing decision to resign and rediscover …
Electrolytes—essential minerals such as calcium, potassium, and magnesium—play a critical role in maintaining various physiological functions. In oncology, the importance of monitoring and managing electrolytes cannot be overstated. Electrolyte imbalances can not only signal the presence of malignancies but also influence the safety and efficacy of cancer treatments. This blog explores the significance of key …
Bladder cancer, particularly muscle-invasive bladder cancer (MIBC), poses significant treatment challenges due to its high recurrence rate and aggressive nature. Traditionally, neoadjuvant chemotherapy followed by surgery (radical cystectomy) has been the standard of care for cisplatin-eligible patients. However, researchers have been exploring ways to improve outcomes by incorporating immunotherapy into treatment. A recent phase 3 …